• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性冠状动脉综合征患者初始TIMI血流不佳的预后

Outcome of poor initial TIMI flow in patients presenting with acute coronary syndrome.

作者信息

Nammas Wail, Pietilä Mikko, Romppanen Hannu, Sia Jussi, DeBelder Adam, Karjalainen Pasi P

机构信息

a Heart Center , Satakunta Central Hospital , Pori , Finland.

b Heart Center , Turku University Hospital , Turku , Finland.

出版信息

Scand Cardiovasc J. 2017 Oct;51(5):248-254. doi: 10.1080/14017431.2017.1346278. Epub 2017 Jun 30.

DOI:10.1080/14017431.2017.1346278
PMID:28666394
Abstract

OBJECTIVES

We explored the predictors and outcome of poor, versus good, initial TIMI flow in patients with acute coronary syndrome (ACS).

DESIGN

We performed post-hoc analysis of a randomized trial of patients presenting with ACS who received 2 comparative stents. Poor initial TIMI flow was defined as baseline TIMI flow grade 0/1 at the initial coronary angiography. The primary endpoint was major adverse cardiac events (MACE): a composite of cardiac death, non-fatal myocardial infarction or ischemia-driven target lesion revascularization. Stent thrombosis (ST) was adjudicated according to the criteria of definite ST described by the Academic Research Consortium. Propensity score-matched analysis was performed. We report data after 5-year follow-up.

RESULTS

Of 827 patients enrolled, 279 (33.7%) had initial TIMI 0/1 flow. Median follow-up duration was 5.0 years. Presentation by ST-elevation myocardial infarction and target vessel other than left anterior descending artery predicted initial TIMI 0/1 flow. MACE rate was comparable between the 2 subgroups (14% versus 15.9%, in patients with poor versus good initial TIMI flow, respectively, p = .46). Individual endpoints were comparable (p > .05 for all). Definite ST was more frequent in patients with initial TIMI 0/1 flow (3.6% versus 1.5%, respectively, p = .048). This was driven by more frequent early events (30 days) (p = .036); late/very late events were comparable (p = 1.0).

CONCLUSIONS

Predictors of poor initial TIMI flow included presentation by ST-elevation myocardial infarction, and target vessel other than left anterior descending artery. Definite ST occurred more in patients with poor, versus good, initial TIMI flow, mainly driven by difference in early events.

摘要

目的

我们探讨了急性冠状动脉综合征(ACS)患者初始TIMI血流不佳与良好的预测因素及预后情况。

设计

我们对接受两种对比支架的ACS患者的一项随机试验进行了事后分析。初始TIMI血流不佳定义为初始冠状动脉造影时基线TIMI血流分级为0/1。主要终点是主要不良心脏事件(MACE):包括心源性死亡、非致死性心肌梗死或缺血驱动的靶病变血运重建的复合终点。支架血栓形成(ST)根据学术研究联盟描述的明确ST标准进行判定。进行了倾向评分匹配分析。我们报告了5年随访后的资料。

结果

在纳入的827例患者中,279例(33.7%)初始TIMI血流为0/1。中位随访时间为5.0年。ST段抬高型心肌梗死表现及非左前降支靶血管可预测初始TIMI血流0/1。两个亚组的MACE发生率相当(初始TIMI血流不佳与良好的患者分别为14%和15.9%,p = 0.46)。各个终点相当(所有p均>0.05)。初始TIMI血流为0/1的患者明确ST更常见(分别为3.6%和1.5%,p = 0.048)。这是由更频繁的早期事件(30天内)所致(p = 0.036);晚期/极晚期事件相当(p = 1.0)。

结论

初始TIMI血流不佳的预测因素包括ST段抬高型心肌梗死表现及非左前降支靶血管。明确ST在初始TIMI血流不佳的患者中比良好的患者更常见,主要由早期事件差异所致。

相似文献

1
Outcome of poor initial TIMI flow in patients presenting with acute coronary syndrome.急性冠状动脉综合征患者初始TIMI血流不佳的预后
Scand Cardiovasc J. 2017 Oct;51(5):248-254. doi: 10.1080/14017431.2017.1346278. Epub 2017 Jun 30.
2
Impact of an optical coherence tomography guided approach in acute coronary syndromes: A propensity matched analysis from the international FORMIDABLE-CARDIOGROUP IV and USZ registry.光学相干断层扫描引导方法在急性冠状动脉综合征中的影响:来自国际FORMIDABLE-CARDIOGROUP IV和苏黎世大学医院登记处的倾向匹配分析。
Catheter Cardiovasc Interv. 2017 Aug 1;90(2):E46-E52. doi: 10.1002/ccd.26880. Epub 2016 Dec 28.
3
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.与含有不可降解聚合物的西罗莫司洗脱支架相比,含可生物降解聚合物的比伐卢定洗脱支架在冠状动脉疾病患者中具有更好的安全性和降低支架血栓形成的风险:LEADERS(雷帕霉素从不可降解到可降解涂层支架洗脱)随机、非劣效性试验的最终 5 年报告。
JACC Cardiovasc Interv. 2013 Aug;6(8):777-89. doi: 10.1016/j.jcin.2013.04.011.
4
A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.新型生物可吸收聚合物西罗莫司洗脱支架与耐用聚合物依维莫司洗脱支架治疗急性冠状动脉综合征患者的随机对照研究:CENTURY II高危急性冠状动脉综合征亚组研究
Cardiovasc Revasc Med. 2016 Sep;17(6):355-61. doi: 10.1016/j.carrev.2016.04.001. Epub 2016 Apr 19.
5
The Pt-Cr everolimus-eluting stent with bioabsorbable polymer in the treatment of patients with acute coronary syndromes. Results from the SYNERGY ACS registry.采用含生物可吸收聚合物的铂铬依维莫司洗脱支架治疗急性冠状动脉综合征患者。SYNERGY ACS注册研究结果。
Cardiovasc Revasc Med. 2019 Aug;20(8):705-710. doi: 10.1016/j.carrev.2018.10.019. Epub 2018 Oct 18.
6
Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial.接受直接经皮冠状动脉介入治疗的右冠状动脉ST段抬高型心肌梗死患者入院心率与血管造影及临床结局的相关性:HORIZONS-AMI(急性心肌梗死血管重建和支架置入的协调结局)试验
J Am Heart Assoc. 2017 Jul 19;6(7):e006181. doi: 10.1161/JAHA.117.006181.
7
Angiographic characteristics of definite stent thrombosis: role of thrombus grade, collaterals, epicardial coronary flow, and myocardial perfusion.明确的支架内血栓形成的血管造影特征:血栓分级、侧支循环、心外膜冠状动脉血流及心肌灌注的作用
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):13-22. doi: 10.1002/ccd.25519. Epub 2014 May 7.
8
Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarction.无聚合物西罗莫司和普罗布考洗脱支架与新一代佐他莫司洗脱支架治疗ST段抬高型心肌梗死患者的五年随访
Catheter Cardiovasc Interv. 2017 Feb 15;89(3):367-374. doi: 10.1002/ccd.26597. Epub 2016 Jul 5.
9
Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).药物洗脱支架与金属裸支架置入治疗 ST 段抬高型心肌梗死患者的长期疗效:DEDICATION 试验(急性心肌梗死中药物洗脱和远端保护)的 5 年随访结果
JACC Cardiovasc Interv. 2013 Jun;6(6):548-53. doi: 10.1016/j.jcin.2012.12.129. Epub 2013 May 15.
10
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).生物可吸收血管支架与依维莫司洗脱金属支架治疗 ST 段抬高型心肌梗死:倾向评分匹配比较的 1 年结果:BVS-EXAMINATION 研究(生物可吸收血管支架——依维莫司洗脱冠状动脉支架治疗 ST 段抬高型心肌梗死患者的临床评估)。
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):189-197. doi: 10.1016/j.jcin.2014.10.005.